Agilent (A): New Buy Recommendation for This Healthcare Giant


Cowen & Co. analyst Doug Schenkel reiterated a Buy rating on Agilent (NYSE: A) today and set a price target of $80. The company’s shares closed yesterday at $71.68.

According to TipRanks.com, Schenkel is a top 100 analyst with an average return of 27.3% and a 73.9% success rate. Schenkel covers the Healthcare sector, focusing on stocks such as Becton Dickinson, Myriad Genetics, and NanoString Tech.

Agilent has an analyst consensus of Hold.

See today’s analyst top recommended stocks >>

The company has a one-year high of $75 and a one-year low of $60.42. Currently, Agilent has an average volume of 2.09M.

Based on the recent corporate insider activity of 78 insiders, corporate insider sentiment is negative on the stock. Last month, Heidi Fields, a Director at A sold 5,482 shares for a total of $371,296.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab Business.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts